The global breast cancer burden

Future Oncology

Volumn 8, Issue 6, 2012, Pages 697-702

  Benson, John R ^a   Jatoi, Ismail ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

breast cancer; epidemiology; incidence; mortality; screening; time trends; treatment

Indexed keywords

ALCOHOL; ANTINEOPLASTIC AGENT; BRCA1 PROTEIN; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR;

ALCOHOL CONSUMPTION; BODY MASS; BODY WEIGHT; BREAST CANCER; BREAST CARCINOGENESIS; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PATIENT; CANCER REGISTRY; CANCER SCREENING; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ENVIRONMENTAL FACTOR; EXERCISE; GENE EXPRESSION; GLOBAL CHANGE; HEALTH CARE UTILIZATION; HEREDITY; HORMONE SUBSTITUTION; HUMAN; LIFESTYLE; LIFESTYLE MODIFICATION; MAMMOGRAPHY; MENOPAUSAL SYNDROME; NATIONAL HEALTH SERVICE; OBESITY; OVERALL SURVIVAL; PATIENT COMPLIANCE; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; RISK REDUCTION; SECONDARY PREVENTION; SIDE EFFECT; SURVIVAL RATE; TREND STUDY;

BREAST NEOPLASMS; ENVIRONMENT; FEMALE; HUMANS; INCIDENCE; LIFE STYLE;

EID: 84863688143     PISSN: 14796694     EISSN: 17448301     Source Type: Journal    
DOI: 10.2217/fon.12.61     Document Type: Review

References (36)

1. Cancer Statistics Registrations: REGISTRATIONS of Cancer Diagnosed in 2008, England (Edition No. MB1 39). Office for National Statistics. National Statistics, London, UK (2010).
2. Jatoi I, Anderson WF. Breast cancer overdiagnosis with screening mammography. Arch. Int. Med. 169, 999-1000 (2009).
3. Waller M, Moss S, Watson J et al. The effect of mammographic screening and hormone replacement therapy use on breast cancer incidence in England and Wales. Cancer Epidemiol. Biomarkers Prev. 16, 2257-2261 (2007).
4. Roussouw JE, Anderson GL, Prentice RL et al.; Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the Women's Health Initiative randomized controlled trial. JAMA 288, 321-333 (2002).
5. Ravdin PM, Cronin KA, Howlader N et al. The decrease in breast cancer incidence in 2003 in the United States. N. Engl. J. Med. 356, 1670-1674 (2007).
6. Desantis C, Howlader N, Cronin KA et al. Breast cancer incidence rates in US women are no longer declining. Cancer Epidemiol. Biomarkers Prev. 20, 733-739 (2011).
7. Zahl PH, Maehlen JA. A decline in breast cancer incidence. N. Engl. J. Med. 357, 509-513 (2007).
8. Elfenbein GJ. A decline in breast cancer incidence. N. Engl. J. Med. 357, 509-513 (2007).
9. Bodmer WF. Inherited susceptibility to cancer. In: INTRODUCTION to the Cellular and Molecular Biology of Cancer (2nd Edition). Frank LM, Teich NM (Eds). Oxford University Press, NY, USA, 98-124 (1995).
10. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell 100, 57-70 (2000).
11. Esteller M. Epigenetic gene silencing in cancer: The DNA hypermethylome. Hum. Mol. Genet. 16(Spec No 1), R50-R59 (2007).
12. Berry DA, Cronin KA, Plevritis SK et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N. Engl. J. Med. 353, 1784-1792 (2005).
13. Porter P. 'Westernizing' women's risks? Breast cancer in lower income countries. N. Engl. J. Med. 358, 213-216 (2008).
14. Coleman MP, Quaresma M, Berrino F et al. Cancer survival in five continents: A worldwide population-based study. Lancet Oncol. 9, 730-756 (2008).
15. Linos E, Spanos D, Rosner BA et al. Effects of reproductive and demographic changes on breast cancer incidence in China: A modeling analysis. J. Natl Cancer Inst. 100, 1352-1360 (2008).
16. Hery C, Ferly J, Boniol M et al. Changes in breast cancer incidence and mortality in middle-Aged and elderly women in 28 countries with caucasian majority populations. Ann. Oncol. 19, 1009-1018 (2008).
17. Autier P, Boniol M, La Vecchia C et al. Disparities in breast cancer mortality trends between 30 European countries: Retrospective trend analysis of WHO mortality database. Br. Med. J. 341, C4480 (2010).
18. Barnett GC, Shah M, Redman K et al. Risk factors for the incidence of breast cancer: Do they affect survival from the disease? J. Clin. Oncol. 26, 3310-3316 (2008).
19. Holmberg L, Iversen OE, Rudenstam CM et al. Increased risk of recurrence after hormone replacement therapy in breast cancer survivors. J. Natl Cancer Inst. 100, 475-482 (2008).
20. Danaei G, Vander Hoorn S, Lopez AD et al. Causes of cancer in the world: Comparative risk assessment of nine behavioural and environmental risk factors. Lancet 366, 1784-1793 (2005).
21. La Vecchia C. The impact of lifestyle on breast cancer. 7th European Breast Cancer Conference. Barcelona, Spain, 24-27 March 2010.
22. Bianchini F, Kaaks R, Vainio H. Overweight, obesity and cancer risk. Lancet Oncol. 3, 565-574 (2002).
23. Renehan AG, Tyson M, Egger M et al. Body-mass index and incidence of cancer: A systematic review and meta-Analysis of prospective observational studies. Lancet 371, 569-578 (2008).
24. Berclaz G, Li S, Price KN et al. Body mass index as a prognostic feature in operable breast cancer: The International Breast Cancer Study Group experience. Ann. Oncol. 15, 875-884 (2004).
25. Calle EE, Rodriguez C, Walker-Thurmand K et al. Overweight, obesity and mortality from cancer in a prospectively studied cohort of US adults. N. Engl. J. Med. 348, 1625-1638 (2003).
26. Jatoi I, Anderson WF, Jeong JH, Redmond CK. Breast cancer adjuvant therapy: Time to consider its time-dependent effects. J. Clin. Oncol. 29, 2301-2304 (2011).
27. Allen NE, Beral V, Casabonne D et al. Moderate alcohol intake and cancer incidence in women. J. Natl Cancer Inst. 101, 296-305 (2009).
28. Kwan ML, Kushi LH, Weltzien E et al. Alcohol consumption and breast cancer recurrence and survival among women with early stage breast cancer: The life after cancer epidemiology study. J. Clin. Oncol. 28(29), 4410-4416 (2010).
29. Sprague BL, Trentham-Dietz A, Newcomb PA et al. Lifetime recreational and occupational physical activity and risk of in situ and invasive breast cancer. Cancer Epidemiol. Biomarkers Prev. 16(2), 236-243 (2007).
30. Holmes MD, Chen WY, Feskanich D et al. Physical activity and survival after breast cancer diagnosis. JAMA 293(20), 2479-2486 (2005).
31. Hesketh T, Lu L, Xing ZW. The effect of China's one-child family policy after 25 years. N. Engl. J. Med. 353, 1171-1176 (2005).
32. Sankaranarayanan R, Ramadas K, Thara S et al. Clinical breast examination: Preliminary results from a cluster randomized controlled trial in India. J. Natl Cancer Inst. 103(19), 1476-1480 (2011).
33. Anderson BO, Shyyan R, Enui A et al. Breast cancer in limited-resource countries: An overview of the Breast Health Global Intiative 2005 guidelines. Breast J. 12(Suppl. 1), S3-S15 (2006).
34. Adami HO, Hansen J, Jung B, Rimsten AJ. Age at first birth, parity and risk of breast cancer in a Swedish population. Br. J. Cancer 42, 651-658 (1980).
35. Cleary MP, Maihle NJ. The role of body mass index in the relative risk of developing premenopausal versus postmenopausal breast cancer. Proc. Soc. Exp. Biol. Med. 216, 28-43 (1997).
36. Anderson WF, Matsuno RK, Sherman ME et al. Estimating age-specific breast cancer risks: A descriptive tool to identify age interactions. Cancer Causes Control 18, 439-447 (2007).